Addressing this challenge, a recent study by Vanguri et al.47 developed a dynamic deep attention-based multiple-instance learning model that integrates radiology, pathology, and multiomics data to predict the response of NSCLC patients treated with anti-PD-1/PD-L1 blockade. Here, CD274 is linked to non-small cell lung carcinoma.